These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

651 related articles for article (PubMed ID: 27225966)

  • 21. Relationship between antibiotic use and incidence of MexXY-OprM overproducers among clinical isolates of Pseudomonas aeruginosa.
    Hocquet D; Muller A; Blanc K; Plésiat P; Talon D; Monnet DL; Bertrand X
    Antimicrob Agents Chemother; 2008 Mar; 52(3):1173-5. PubMed ID: 18180356
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A new member of the tripartite multidrug efflux pumps, MexVW-OprM, in Pseudomonas aeruginosa.
    Li Y; Mima T; Komori Y; Morita Y; Kuroda T; Mizushima T; Tsuchiya T
    J Antimicrob Chemother; 2003 Oct; 52(4):572-5. PubMed ID: 12951344
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phage Resistance Evolution Induces the Sensitivity of Specific Antibiotics in Pseudomonas aeruginosa PAO1.
    Xuan G; Lin H; Kong J; Wang J
    Microbiol Spectr; 2022 Oct; 10(5):e0135622. PubMed ID: 35972274
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Detection of drug-resistance mechanism of Pseudomonas aeruginosa developing from a sensitive strain to a persister during carbapenem treatment.
    Shen JL; Fang YP
    Genet Mol Res; 2015 Jun; 14(2):6723-32. PubMed ID: 26125881
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A Novel indole compound that inhibits Pseudomonas aeruginosa growth by targeting MreB is a substrate for MexAB-OprM.
    Robertson GT; Doyle TB; Du Q; Duncan L; Mdluli KE; Lynch AS
    J Bacteriol; 2007 Oct; 189(19):6870-81. PubMed ID: 17644596
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Resistance against antimicrobial peptides is independent of Escherichia coli AcrAB, Pseudomonas aeruginosa MexAB and Staphylococcus aureus NorA efflux pumps.
    Rieg S; Huth A; Kalbacher H; Kern WV
    Int J Antimicrob Agents; 2009 Feb; 33(2):174-6. PubMed ID: 18945595
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efflux as a mechanism of resistance to antimicrobials in Pseudomonas aeruginosa and related bacteria: unanswered questions.
    Schweizer HP
    Genet Mol Res; 2003 Mar; 2(1):48-62. PubMed ID: 12917802
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Enhanced efficacy of putative efflux pump inhibitor/antibiotic combination treatments versus MDR strains of Pseudomonas aeruginosa in a Galleria mellonella in vivo infection model.
    Adamson DH; Krikstopaityte V; Coote PJ
    J Antimicrob Chemother; 2015 Aug; 70(8):2271-8. PubMed ID: 25921513
    [TBL] [Abstract][Full Text] [Related]  

  • 29. RND efflux pump mediated antibiotic resistance in Gram-negative bacteria Escherichia coli and Pseudomonas aeruginosa: a major issue worldwide.
    Puzari M; Chetia P
    World J Microbiol Biotechnol; 2017 Feb; 33(2):24. PubMed ID: 28044273
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A permeability-increasing drug synergizes with bacterial efflux pump inhibitors and restores susceptibility to antibiotics in multi-drug resistant Pseudomonas aeruginosa strains.
    Ferrer-Espada R; Shahrour H; Pitts B; Stewart PS; Sánchez-Gómez S; Martínez-de-Tejada G
    Sci Rep; 2019 Mar; 9(1):3452. PubMed ID: 30837499
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of efflux pumps: MexAB-OprM and MexXY(-OprA), AmpC cephalosporinase and OprD porin in non-metallo-β-lactamase producing Pseudomonas aeruginosa isolated from cystic fibrosis and burn patients.
    Aghazadeh M; Hojabri Z; Mahdian R; Nahaei MR; Rahmati M; Hojabri T; Pirzadeh T; Pajand O
    Infect Genet Evol; 2014 Jun; 24():187-92. PubMed ID: 24694825
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Study of the diversity in a group of phages of Pseudomonas aeruginosa species PB1 (Myoviridae) and their behavior in adsorbtion-resistant bacterial mutants].
    Pleteneva EA; Shaburova OV; Sykilinda NN; Miroshnikov KA; Krylov SV; Mesianzhinov VV; Krylov VN
    Genetika; 2008 Feb; 44(2):185-94. PubMed ID: 18619036
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Utility of lytic bacteriophage in the treatment of multidrug-resistant Pseudomonas aeruginosa septicemia in mice.
    Vinodkumar CS; Kalsurmath S; Neelagund YF
    Indian J Pathol Microbiol; 2008; 51(3):360-6. PubMed ID: 18723958
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pseudomonas aeruginosa reveals high intrinsic resistance to penem antibiotics: penem resistance mechanisms and their interplay.
    Okamoto K; Gotoh N; Nishino T
    Antimicrob Agents Chemother; 2001 Jul; 45(7):1964-71. PubMed ID: 11408209
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Functional interaction sites of OprM with MexAB in the Pseudomonas aeruginosa multidrug efflux pump.
    Yoshihara E; Eda S; Kaitou S
    FEMS Microbiol Lett; 2009 Oct; 299(2):200-4. PubMed ID: 19709308
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro transport activity of the fully assembled MexAB-OprM efflux pump from Pseudomonas aeruginosa.
    Verchère A; Dezi M; Adrien V; Broutin I; Picard M
    Nat Commun; 2015 Apr; 6():6890. PubMed ID: 25901994
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The mode of action of 2-(thiazol-2-ylthio)-1beta-methylcarbapenems against Pseudomonas aeruginosa: the impact of outer membrane permeability and the contribution of MexAB-OprM efflux system.
    Eguchi K; Ueda Y; Kanazawa K; Sunagawa M; Gotoh N
    J Antibiot (Tokyo); 2007 Feb; 60(2):129-35. PubMed ID: 17420563
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efflux pump inhibitors reduce the invasiveness of Pseudomonas aeruginosa.
    Hirakata Y; Kondo A; Hoshino K; Yano H; Arai K; Hirotani A; Kunishima H; Yamamoto N; Hatta M; Kitagawa M; Kohno S; Kaku M
    Int J Antimicrob Agents; 2009 Oct; 34(4):343-6. PubMed ID: 19615866
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Antibiotic Efflux Protein TolC Is a Highly Evolvable Target under Colicin E1 or TLS Phage Selection.
    Tamer YT; Gaszek I; Rodrigues M; Coskun FS; Farid M; Koh AY; Russ W; Toprak E
    Mol Biol Evol; 2021 Sep; 38(10):4493-4504. PubMed ID: 34175926
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multiple genotypic changes in hypersusceptible strains of Pseudomonas aeruginosa isolated from cystic fibrosis patients do not always correlate with the phenotype.
    Wolter DJ; Black JA; Lister PD; Hanson ND
    J Antimicrob Chemother; 2009 Aug; 64(2):294-300. PubMed ID: 19468029
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 33.